HUP0303285A3 - Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence - Google Patents

Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence

Info

Publication number
HUP0303285A3
HUP0303285A3 HU0303285A HUP0303285A HUP0303285A3 HU P0303285 A3 HUP0303285 A3 HU P0303285A3 HU 0303285 A HU0303285 A HU 0303285A HU P0303285 A HUP0303285 A HU P0303285A HU P0303285 A3 HUP0303285 A3 HU P0303285A3
Authority
HU
Hungary
Prior art keywords
antagonists
preparing
pharmaceutical composition
urinary incontinence
opioid agonists
Prior art date
Application number
HU0303285A
Other languages
English (en)
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HUP0303285A2 publication Critical patent/HUP0303285A2/hu
Publication of HUP0303285A3 publication Critical patent/HUP0303285A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HU0303285A 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence HUP0303285A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10059415A DE10059415A1 (de) 2000-11-30 2000-11-30 Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz
PCT/EP2001/013911 WO2002043713A2 (de) 2000-11-30 2001-11-28 Verwendung von schwachen opioiden und gemischten opioidagonisten / -antagonisten zur therapie der harninkontinenz

Publications (2)

Publication Number Publication Date
HUP0303285A2 HUP0303285A2 (hu) 2004-01-28
HUP0303285A3 true HUP0303285A3 (en) 2005-05-30

Family

ID=7665212

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303285A HUP0303285A3 (en) 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence

Country Status (14)

Country Link
US (1) US7008939B2 (hu)
EP (1) EP1337254B1 (hu)
JP (1) JP2004527465A (hu)
AT (1) ATE287265T1 (hu)
AU (2) AU2073602A (hu)
CA (1) CA2430281C (hu)
DE (2) DE10059415A1 (hu)
ES (1) ES2234933T3 (hu)
HU (1) HUP0303285A3 (hu)
MX (1) MXPA03004713A (hu)
NZ (1) NZ526604A (hu)
PL (1) PL204246B1 (hu)
PT (1) PT1337254E (hu)
WO (1) WO2002043713A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476280B2 (en) 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
US7964315B2 (en) * 2003-09-12 2011-06-21 Bdf Ip Holdings Ltd. Shutdown methods and designs for fuel cell stacks
JP4902883B2 (ja) * 2005-03-11 2012-03-21 ビーディーエフ アイピー ホールディングス リミテッド 燃料電池スタックのシャットダウン方法および設計
TW200800223A (en) * 2005-12-21 2008-01-01 Shire Pharmaceuticals Inc Transdermal delivery of meptazinol
JP2011500686A (ja) * 2007-10-18 2011-01-06 アイコ バイオテクノロジー オピオイドと中性アンタゴニストを用いる組合せ鎮痛剤
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
CN102836122A (zh) * 2011-06-24 2012-12-26 扬子江药业集团四川海蓉药业有限公司 含有盐酸美普他酚的组合物注射液及其制备方法
CN105362213A (zh) * 2015-02-13 2016-03-02 成都苑东药业有限公司 一种盐酸美普他酚注射液药物组合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
USRE36547E (en) * 1992-09-21 2000-02-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
KR100341829B1 (ko) * 1996-03-08 2002-08-22 니코메드 덴마크 에이/에스 방출특성이변형된다-유니트투여량조성물
US5859043A (en) * 1996-06-11 1999-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for maintaining kidney function during surgery or severe trauma under general anesthesia
DE69830728T2 (de) * 1997-04-11 2006-05-18 Nippon Shinyaku Co., Ltd. Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
US5840696A (en) * 1997-09-11 1998-11-24 Lippton; Howard Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
EP0913152B1 (de) * 1997-11-03 2001-12-19 Stada Arzneimittel Ag Stabilisiertes Kombinationsarzneimittel enthaltend Naloxone und ein Opiatanalgetikum
DE19947747A1 (de) * 1999-10-05 2001-04-12 Gruenenthal Gmbh Verwendung von (+)-Tramadol, O-Demethyltramadol bzw. (+)-O-Demethyltramadol zur Therapie der Harninkontinenz
US8410129B2 (en) * 2002-02-15 2013-04-02 Howard Brooks-Korn Treatment for paresis/paralysis

Also Published As

Publication number Publication date
WO2002043713A2 (de) 2002-06-06
US7008939B2 (en) 2006-03-07
US20040029905A1 (en) 2004-02-12
ATE287265T1 (de) 2005-02-15
NZ526604A (en) 2005-04-29
JP2004527465A (ja) 2004-09-09
CA2430281C (en) 2009-08-25
PL363677A1 (en) 2004-11-29
CA2430281A1 (en) 2002-06-06
HUP0303285A2 (hu) 2004-01-28
DE10059415A1 (de) 2002-06-06
EP1337254B1 (de) 2005-01-19
EP1337254A2 (de) 2003-08-27
WO2002043713A3 (de) 2002-10-31
AU2002220736B2 (en) 2006-04-06
AU2073602A (en) 2002-06-11
ES2234933T3 (es) 2005-07-01
DE50105150D1 (de) 2005-02-24
PT1337254E (pt) 2005-05-31
PL204246B1 (pl) 2009-12-31
MXPA03004713A (es) 2003-08-19

Similar Documents

Publication Publication Date Title
HUP0203458A3 (en) Nociceptin receptor orl-1 agonists for use in treating cough and pharmaceutical compositions containing them
HUP0401485A3 (en) Pharmaceutical composition containing combination of selected opioids with muscarine antagonists for treating urinary incontinence
HUP0103767A3 (en) Use of estrogen agonist/antagonist for preparation of pharmaceutical compositions available for treating osteoarthritis
IL149600A0 (en) Novel methods and compositions involving opioids and antagonists thereof
HUP0204340A3 (en) Compositions for delivery of a cortisol antagonist and their use
HUP0401195A3 (en) Compositions to prevent abuse of opioids containing aversive agent and process of their preparation
PT1255547E (pt) Composições de libertação controlada contendo agonistas e antagonistas opióides
HUP0203564A3 (en) Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinease, process for their preparation and pharmaceutical compositions containing them
HUP0400349A3 (en) Ccr5 antagonists useful for treating aids and pharmaceutical compositions containing them
AU2002213409A1 (en) Galphaqproetin variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
HUP0303285A3 (en) Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence
AU5956001A (en) Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
AU2002220736A1 (en) Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
HUP0104374A3 (en) Growth hormone releasing compounds and their antagonists for use for treatment of tumors
HUP0204511A3 (en) Use of ppar activator or ligand in preparation of pharmaceutical compositions for treatment of bone diseas
AU6482200A (en) Use of amh and/or amh agonists and/or amh antagonists for long-term control of female fertility
AU2003240717A1 (en) Combination of selected opioids with other active substances for use in the therapy of urinary incontinence
EG22668A (en) Composition formed of polyolefins process for their preparation and use of these compositions
IL152180A0 (en) Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
HUP0300860A3 (en) Pharmaceutical compositions suitable for treatment of urinary dysfunction
SI1337254T1 (en) Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
HUP0303046A3 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence and pharmaceutical compositions containing them
HUP0302984A3 (en) Utilization of buprenorphine for preparation of pharmaceutical composition useful in urinary incontinence therapy
HUP0303268A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
EP1099441A3 (en) Compositions containing apo B secretion/MTP inhibitors and anti-obesity agents and use thereof

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished